Seattle Cancer Care Alliance provides comprehensive, leading-edge treatment for people diagnosed with kidney cancers, including renal cell carcinoma, which accounts for 90 percent of kidney tumors in adults. Most kidney cancers are initially treated with surgery. Advanced kidney cancer that has returned after surgery or spread to other organs is difficult to treat. Most kidney cancers do not respond to traditional chemotherapy. But there is hope with biologic/immunotherapy as well as a new generation of targeted therapies. Currently, the best type of treatment for kidney cancer is participation in a clinical study.
SCCA was formed in part to bring promising new treatments to patients faster. This means that people who have kidney cancer will find more treatment options at SCCA than might be found elsewhere, including participation in one of the clinical studies conducted at SCCA and its founding organizations, Fred Hutchinson Cancer Research Center and UW Medicine.